RADX
Radiopharm Theranostics Ltd - ADR

999
Mkt Cap
$39.34M
Volume
21,453.00
52W High
$16.25
52W Low
$3.50
PE Ratio
-1.44
RADX Fundamentals
Price
$4.99
Prev Close
$4.98
Open
$4.95
50D MA
$5.09
Beta
0.00
Avg. Volume
48,652.10
EPS (Annual)
-$3.43
P/B
1.34
$11.85
Loading...
Loading...
News
all
press releases
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Given Consensus Rating of "Buy" by Brokerages
Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) have received a consensus rating of "Buy" from the five ratings firms that are currently covering the stock...
MarketBeat·12d ago
News Placeholder
More News
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Up 112.6% in January
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) saw a significant growth in short interest in the month of January. As of January 30th, there was short interest...
MarketBeat·17d ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Significant Decline in Short Interest
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short...
MarketBeat·1mo ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Large Increase in Short Interest
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest...
MarketBeat·2mo ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Update
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short...
MarketBeat·2mo ago
News Placeholder
Radiopharm Theranostics (NASDAQ:RADX) Earns "Buy" Rating from B. Riley
B. Riley restated a "buy" rating and set a $16.00 price objective (up previously from $13.00) on shares of Radiopharm Theranostics in a report on Tuesday...
MarketBeat·3mo ago
News Placeholder
Tesla, iRobot, ServiceNow, Radiopharm Theranostics, Kyverna Therapeutics: Stocks Making The Biggest Moves Today
Tesla shares were up nearly 4% in Monday’s midday trade after CEO Elon Musk stated in a post on Sunday that the EV giant had begun fully autonomous testing of Robotaxis in Austin.
Stocktwits·3mo ago
<
...
1
>

Latest RADX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.